论文部分内容阅读
据出席欧洲心脏病学会心衰会议(HF)的法国研究人员报道,调查结果表明肾功能不全的充血性心衰患者治疗心衰时服用的药物剂量明显不足。法国研究人员发现,慢性肾功能不全与慢性心衰患者的不良预后直接关联;而患者肾功能不全的确诊可能又与有效治疗心衰的药物剂量不足存在某种关联。研究人员对法国1917例充血性心衰的门诊患者进行了调查分析。这些受调查的患者平均年龄为70岁,平均左心室射血指数(LVEF)为33%。根据美国纽约心脏病学会的评估标准检测显示,被调查的95%的心衰患者的心功能等级为Ⅱ～Ⅳ级;并依据患者的肌酸酐水平大于220 mcmol/L时确诊为肾功能不全。调查结果发现,受试者中有249例患者肾功能不全(13%)。其中,与73%的肾功能正常的心衰
According to French researchers who attended the European Society of Cardiology’s Heart Failure Conference (HF), the survey showed that patients with renal insufficiency and congestive heart failure had significantly under-treated medications for treating heart failure. French researchers found that chronic renal insufficiency is directly linked to poor prognosis in patients with chronic heart failure; and the diagnosis of renal insufficiency in patients with renal insufficiency may be associated with insufficient drug dose effective treatment of heart failure. Researchers conducted a survey of 1917 outpatients with congestive heart failure in France. The average age of these patients surveyed was 70 years and the mean left ventricular ejection fraction (LVEF) was 33%. According to the New York Heart Association assessment criteria test, 95% of the heart failure patients were investigated in cardiac function grade Ⅱ ~ Ⅳ level; and based on patients with creatinine levels greater than 220 mcmol / L was diagnosed with renal insufficiency. The survey found that 249 of the subjects had renal insufficiency (13%). Among them, with 73% of normal renal failure